AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (420.3 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Corrigendum | Open Access

Corrigendum to “N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis” [Genes & Diseases 10 (2023) 554—567]

Wan-Xin Penga,b( )Fei LiucJia-Hong JiangdHang YuaneZiqiang ZhangfLiu Yangg( )Yin-Yuan Mob,h,1( )
Department of Surgical Oncology, The Children’s Hospital, Zhejiang University School of Medicine, National Research Center for Child Health, Hangzhou, Zhejiang 310052, China
Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS 39216, USA
Department of Nephrology, The Children’s Hospital, Zhejiang University School of Medicine, National Research Center for Child Health, Hangzhou, Zhejiang 310052, China
Department of Medical Oncology, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, China
Department of Colorectal Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, China
Department of Pulmonary Medicine, Tongji Hospital, Tongji University, Shanghai 200065, China
Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, China
Department of Pharmacology/Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA

Peer review under responsibility of Chongqing Medical University.

1 Current affiliation: Institute of Clinical Medicine Research, Zhejiang Provincial People’s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China.

Show Author Information

Genes & Diseases
Article number: 101352
Cite this article:
Peng W-X, Liu F, Jiang J-H, et al. Corrigendum to “N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis” [Genes & Diseases 10 (2023) 554—567]. Genes & Diseases, 2024, 11(6): 101352. https://doi.org/10.1016/j.gendis.2024.101352

68

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics

Published: 15 June 2024
© 2024 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return